Sign up
Pharma Capital

Suspended Patisserie Valerie finance boss Chris Marsh arrested on suspicion of fraud

“The company has been made aware that Chris Marsh, who is currently suspended from his role as company finance director, was arrested by the police last night and has been released on bail”
patisserie valerie
Marsh, who was suspended by his employer earlier this week, was arrested last night

The chief financial officer of Patisserie Holdings PLC (LON:CAKE), the parent company of crisis-hit cake shop chain Patisserie Valerie, has been arrested on suspicion of fraud.

A spokesperson for Hertfordshire Police said: "A 44-year-old man from St Albans has been arrested on suspicion of fraud by false representation. He has been released under investigation."

The case has been passed on to the Serious Fraud Office which is now leading the investigation.

READ: Administrators ‘on stand-by’ at Patisserie Valerie

Marsh was suspended by the AIM company earlier this week while it investigated “significant, and potentially fraudulent, accounting irregularities” which have left it on the verge of bankruptcy.

The company then followed that up a few hours later by revealing it had just found about a winding-up petition from HMRC over a £1.1mln tax bill, despite the order being issued last week.

Capping it all off was an announcement on Thursday afternoon, stating that the company’s actual financial position was worse than feared and that an “immediate injection of capital” would be needed to stop the business from going bust.

READ: How did it come to this? Patisserie Valerie left begging for money

Reports on Friday morning suggested administrators from PwC were on standby and could be brought in as early as today.

The barely believable saga has left investors scratching their heads; a seemingly healthy, profitable company on Tuesday could be wound up by Friday.



Register here to be notified of future Company articles
View full profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.